HIF-1 activation attenuates postischemic myocardial injury: Role for heme oxygenase-1 in modulating microvascular chemokine generation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 289, Issue 2 58-2, 2005, Pages

  Ockaili, Ranizi ^a   Natarajan, Ramesh ^a   Salloum, Fadi ^a   Fisher, Bernard J ^a   Jones, Drew ^a   Fowler III, Alpha A ^a,b   Kukreja, Rakesh C ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiac ischemia reperfusion; Hypoxia inducible factor 1; Interleukin 8

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; DIMER; DIMETHYLOXALYLGLYCINE; GLYCINE DERIVATIVE; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; INTERLEUKIN 8; MYELOPEROXIDASE; PEPTIDE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HEART INFARCTION SIZE; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HYPOXIA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; RABBIT; REGULATORY MECHANISM; REPERFUSION INJURY; TISSUE INJURY;

AMINO ACIDS, DICARBOXYLIC; BLOOD VESSELS; CELLS, CULTURED; CHEMOKINES; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTERLEUKIN-8; MEMBRANE PROTEINS; MICROCIRCULATION; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHIL INFILTRATION; NUCLEAR PROTEINS; PROCOLLAGEN-PROLINE DIOXYGENASE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTORS;

EID: 23744443462     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00089.2005     Document Type: Article

References (43)

1. Ahluwalia A, Foster P, Scotland RS, McLean PG, Mathur A, Perretti M, Moncada S, and Hobbs AJ. Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci USA 101: 1386-1391, 2004.
2. Banerjee A, Locke-Winter CR, Rogers KB, Mitchell MB, Brew EC, Cairns CB, Bensard DD, and Harken AH. Preconditioning against myocardial dysfunction after ischemia and reperfusion by an α1-adrenergic mechanism. Circ Res 73: 656-670, 1993.
3. Baxter GF, Goma FM, and Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159-167, 1997.
4. Boyle EM Jr, Kovacich JC, Hebert CA, Canty TG Jr, Chi E, Morgan EN, Pohlman TH, and Verrier ED. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury. J Thorac Cardiovasc Surg 116: 114-121, 1998.
5. Cohen MV, Liu GS, and Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84: 341-349, 1991.
6. Coulet F, Nadaud S, Agrapart M, and Soubrier F. Identification of hypoxia-response element in the human endothelial nitric-oxide synthase gene promoter. J Biol Chem 278: 46230-46240, 2003.
7. Fowler AA, Fisher BJ, Sweeney LB, Wallace TJ, Natarajan R, Ghosh SS, and Ghosh S. Nitric oxide regulates IL-8 gene expression in activated endothelium by inhibiting NF-κB binding to DNA: effects on endothelial function. Biochem Cell Biol 77: 201-208, 1999.
8. Guo Y, Stein AB, Wu WJ, Tan W, Zhu X, Li QH, Dawn B, Motterlini R, and Bolli R. Administration of a CO-releasing molecule at the time of reperfusion reduces infarct size in vivo. Am J Physiol Heart Circ Physiol 286: H1649-H1653, 2004.
9. Huang LE, Arany Z, Livingston DM, and Bunn HF. Activation of hypoxia-inductble transcription factor depends primarily upon redox-sensitive stabilization of its subunit. J Biol Chem 271: 32253-32259, 1996.
10. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 95: 7987-7992, 1998.
11. Jiang B, Rue E, Wang GL, Roe R, and Semenza GL. Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271: 17771-17778, 1996.
12. Jiang B, Zheng JZ, Leung SW, Roe R, and Semenza GL. Transactivation and inhibitory domains of hypoxia-inducible factor 1: modulation of transcriptional, activity by oxygen tension. J Biol Chem 272: 19253-19260, 1997.
13. Lee PJ, Jiang BH, Chin BY, Iyer NV, Alam J, Semenza GL, and Choi AM. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 272: 5375-5381, 1997.
14. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, and Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
15. Liu Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998.
16. Melillo G, Taylor LS, Brooks A, Musso T, Cox GW, and Varesio L. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem 272: 12236-12243, 1997.
17. Moore MK and Viselli SM. Staining and quantification of proteins transferred to polyvinylidene fluoride membranes. Anal Biochem 279: 241-242, 2000.
18. Mukaida N, Matsumoto T, Yokoi K, Harada A, and Matsushima K. Inhibition of neutrophil-mediated acute inflammation injury by an antibody against interleukin-8. Inflamm Res 47:5151-5157, 1998.
19. Natarajan R, Fisher BJ, Jones DJ, Ghosh S, and Fowler AA. Reoxygenating microvascular endothelium exhibits temporal dissociation of NF-κB and AP-1 activation. Free Radic Biol Med 32: 1033-1045, 2002.
20. Natarajan R, Fisher BJ, Jones DG, and Fowler AA. Atypical mechanism of NF-κB activation during reoxygenation stress in microvascular endothelium: a role for tyrosine kinases. Free Radic Biol Med 33: 962-973, 2002.
21. Neumann FJ, Ott I, Gawaz M, Richardt G, Holzapfel H, Jochum M, and Schomig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92: 748-755, 1995.
22. Ockaili R, Salloum F, Hawkins J, and Kukreja RC. Sildenafil (Viagra) induces powerful cardioprotective effect via opening of mitochondrial KATP channels in rabbits. Am J Physiol Heart Circ Physiol 283: H1263-H1269, 2002.
23. Ockaili RA, Bhargava P, and Kukreja RC. Chemical preconditioning with 3-nitropropionic acid in hearts: role of mitochondrial KATP channel. Am J Physiol Heart Circ Physiol 280: H2406-H2411, 2001.
24. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C, Ulevitch RJ, Knickelbein R, Flavell RA, and Choi AM. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Am J Pathol 163: 2555-2563, 2003.
25. Qi X, Li J, Gu J, Li S, Dang Y, and Wang T. Plasma levels of IL-8 predict early complications in patients with coronary heart disease after percutaneous coronary intervention. Jpn Heart J 44: 451-461, 2003.
26. Riesenberg K, Levy R, Katz A, Galkop S, and Schlaeffer F. Neutrophil superoxide release and interleukin-8 in acute myocardial infarction: distinction between complicated and uncomplicated states. Eur J Clin Invest 27: 398-404, 1997.
27. Salloum F, Yin C, Xi L, and Kukreja RC. Sildenafil induces delayed preconditioning through inducible nitric oxide synthase-dependent pathway in mouse heart. Circ Res 92: 595-597, 2003.
28. 1- but not μ- or κ-opioid receptors. Circulation 97: 1282-1289, 1998.
29. Sekido N, Mukaida N, Harada A, Nakanishi I, and Watanabe Y, and Matsushima K. Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature 365: 654-657, 1993.
30. Semenza GL. HIF-1 and human disease: one highly involved factor. Genes Dev 14: 1983-1991, 2000.
31. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, and Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1. J Biol Chem 271: 32529-32537, 1996.
32. Shin WS, Szuba A, and Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 160: 91-102, 2002.
33. Stein AB, Guo Y, Tan W, Wu WJ, Zhu X, Li Q, Luo C, Dawn B, Johnson TR, Motterlini R, and Bolli R. Administration of a CO-releasing molecule induces late preconditioning against myocardial infarction. J Mol Cell Cardiol 38: 127-134, 2005.
34. Sutter CH, Laughner E, and Semenza GL. HIF-1α protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci USA 97: 4748-4753, 2000.
35. Tejero-Taldo MI, Gursoy E, Zhao TC, and Kukreja RC. α-Adrenergic receptor stimulation produces late preconditioning through inducible nitric oxide synthase in mouse heart. J Mol Cell Cardiol 34: 185-195, 2002.
36. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, and Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80: 743-748, 1997.
37. Turcanu V, Dhouib M, and Poindron P. Determination of heme oxygenase activity in murine macrophages for studying oxidative stress inhibitors. Anal Biochem 263: 251-253, 1998.
38. Wang GL and Semenza GL. Purification and characterization of hypoxia-inducible factor 1. J Biol Chem 270: 1230-1237, 1995.
39. 2 tension. Proc Natl Acad Sci USA 92: 5510-5514, 1995.
40. Xi L, Salloum F, Tekin D, Jarrett NC, and Kukreja RC. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice. Am J Physiol Heart Circ Physiol 277: H2418-H2424, 1999.
41. Yet SF, Tian R, Layne MD, Wang ZY, Maemura K, Solovyeva M, Ith B, Melo LG, Zhang L, Ingwall JS, Dzau VJ, Lee ME, and Perrella MA. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res 89: 168-173, 2001.
42. Zhao T, Xi L, Chelliah J, Levasseur JE, and Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine AI receptors: evidence from gene-knockout mice. Circulation 102: 902-907, 2000.
43. Zhao TC, Taher MM, Valerie KC, and Kukreja RC. p38 Triggers late preconditioning elicited by anisomycin in heart: involvement of NF-κB and iNOS. Circ Res 89: 915-922, 2001.